Company / Gross Profit
Beta Bionics, Inc. Gross Profit History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$55.5M
FY2025
5-year range
$6.3M / $55.5M
FY2023-FY2025
Trend
+54.8%
vs FY2024
Sector context
#97 of 100
Health Care
What the data says
Among 100 Health Care companies, Beta Bionics, Inc. is in the bottom 3% for gross profit. Improved from $6M to $56M over the past 2 years.
Based on SEC 10-K filings.
$56M in FY2025.
Improved from $6M to $56M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 100This company $55.5M Sector average $1.8B
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, gross profit increased 54.8% year-over-year.
- Ranks #97 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.5M | +54.8% |
| FY2024 | $35.9M | +468.9% |
| FY2023 | $6.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026